Your browser doesn't support javascript.
loading
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Harter, Philipp; Mouret-Reynier, Marie Ange; Pignata, Sandro; Cropet, Claire; González-Martín, Antonio; Bogner, Gerhard; Fujiwara, Keiichi; Vergote, Ignace; Colombo, Nicoletta; Nøttrup, Trine Jakobi; Floquet, Anne; El-Balat, Ahmed; Scambia, Giovanni; Guerra Alia, Eva Maria; Fabbro, Michel; Schmalfeldt, Barbara; Hardy-Bessard, Anne-Claire; Runnebaum, Ingo; Pujade-Lauraine, Eric; Ray-Coquard, Isabelle.
Affiliation
  • Harter P; Ev. Kliniken Essen Mitte, Essen, and Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Studiengruppe, Germany. Electronic address: P.Harter@kem-med.com.
  • Mouret-Reynier MA; Centre Jean Perrin, Clermont, and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), France.
  • Pignata S; Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Italy.
  • Cropet C; Centre Léon Bérard, Lyon, France.
  • González-Martín A; MD Anderson Cancer Center Madrid, and Grupo Español de Investigación en Cáncer de Ovario (GEICO), Spain.
  • Bogner G; Paracelsus Medical University Salzburg, Salzburg, and Arbeitsgemeinschaft Gynaekologische Onkologie (AGO Austria), Austria.
  • Fujiwara K; Saitama Medical University International Medical Center, Hidaka, and Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Japan.
  • Vergote I; University Hospital Leuven, Leuven Cancer Institute, Leuven, and Belgian Gynaecological Oncology Group (BGOG), Belgium.
  • Colombo N; University of Milan-Bicocca and IEO European Institute of Oncology IRCCS, Milan, and Mario Negri Gynecologic Oncology Group (MANGO), Italy.
  • Nøttrup TJ; Copenhagen University Hospital, Copenhagen, and Nordic Society of Gynecologic Oncology (NSGO), Denmark.
  • Floquet A; Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, and GINECO, France.
  • El-Balat A; Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt, and AGO, Germany.
  • Scambia G; Fondazione Policlinico Universitario A. Gemelli IRCCS Università Cattolica, Rome, and MITO, Italy.
  • Guerra Alia EM; Hospital Universitario Ramón y Cajal, Madrid, and GEICO, Spain.
  • Fabbro M; ICM Val d'Aurelle, Montpellier, and GINECO, France.
  • Schmalfeldt B; Universitätsklinikum Hamburg-Eppendorf, Hamburg, and AGO, Germany.
  • Hardy-Bessard AC; Centre CARIO - HPCA, Plérin sur mer, and GINECO, France.
  • Runnebaum I; Universitätsklinikum Jena, Jena, and AGO, Germany.
  • Pujade-Lauraine E; Association de Recherche Cancers Gynécologiques (ARCAGY), Paris, and GINECO, France.
  • Ray-Coquard I; Centre Léon BERARD and University Claude Bernard Lyon 1, Lyon, and GINECO, France.
Gynecol Oncol ; 164(2): 254-264, 2022 02.
Article in En | MEDLINE | ID: mdl-34952708
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Phthalazines / Piperazines / Hereditary Breast and Ovarian Cancer Syndrome / Bevacizumab / Poly(ADP-ribose) Polymerase Inhibitors / Antineoplastic Agents, Immunological / Carcinoma, Ovarian Epithelial Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Phthalazines / Piperazines / Hereditary Breast and Ovarian Cancer Syndrome / Bevacizumab / Poly(ADP-ribose) Polymerase Inhibitors / Antineoplastic Agents, Immunological / Carcinoma, Ovarian Epithelial Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2022 Document type: Article Country of publication: